Clin2
NCT05479305Possibly a fitRecruiting

Stent placement for thoracic aorta problems in urgent high-risk patients

Penetrating Ulcer of AortaAneurysm AorticType B Aortic DissectionResidual Dissection After Type A Repair

Part of Heart & circulation clinical trials.

This trial studies a new type of stent graft placed in the chest aorta (from the aortic arch into the descending part) to treat aneurysms or dissections in people who are too high-risk for open surgery. It may help by offering a faster, less invasive repair when waiting for a custom stent would be unsafe.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older and able to sign informed consent.
  • Your main problem must be in the thoracic aorta/arch, such as an aneurysm, penetrating ulcer, Type B dissection, or a residual dissection after prior Type A repair.
  • The doctor must plan to treat blood flow to the arch branches (BT, LCCA, LSA) and you must be high-risk but stable enough to tolerate the procedure.
  • Your imaging must show healthy “landing zones” (seal areas) in the aorta with enough length, and no clot in the neck area.
  • Your aorta and branch vessel sizes/shape must fit the device limits, and the access arteries (arm/groin) must be suitable for device delivery.
  • You must not need emergency treatment right away, and you must have kidney function and overall health that allow contrast imaging and follow-up.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03111459Recruiting
Endovascular repair for large thoracoabdominal aortic aneurysms

This trial studies a minimally invasive (endovascular) procedure to repair large or risky aneurysms in the aorta near the chest and abdomen. It may help prevent aneurysm rupture and improve outcomes compared with other possible treatments.

Cincinnati, Ohio
NCT02201589Recruiting
Endovascular repair for certain ascending aorta problems

This trial studies whether a minimally invasive (endovascular) procedure can safely treat specific serious problems of the ascending aorta. It may help people who are too high-risk for standard open-heart surgery, but only if their anatomy fits and certain risks are ruled out.

Long Beach, California
NCT05054985Recruiting
Stent graft for thoracoabdominal aortic aneurysm

This trial tests a specialized multi-branch stent graft to treat a large or growing aneurysm in the aorta near the chest and abdomen. It mainly looks at safety and whether the stent keeps blood flowing to important arteries.

Beijing, Beijing Municipality
NCT02323581Recruiting
Stent procedure for large aortic aneurysms with custom grafts

This trial studies a less invasive “through-the-blood-vessel” stent graft procedure for large aneurysms in the main aorta or the aortic arch. It may help reduce the risk of aneurysm rupture while avoiding open surgery for people at higher surgical risk.

New York, New York
NCT05803564Recruiting
Stent placement study for a torn, bulging main artery

This trial tests a specialized stent (a small mesh tube) placed inside the chest and belly aorta to treat a thoracoabdominal aortic dissecting aneurysm. It may help prevent the artery from getting bigger or causing dangerous bleeding by supporting the weakened area from inside.

Beijing, Beijing Municipality
NCT06710938Recruiting
Stent graft for thoracoabdominal aortic aneurysm

This trial tests a new stent graft system for treating a thoracoabdominal aortic aneurysm, a bulging of the main blood vessel in your chest and belly. It may be an option if your aneurysm is large, growing, or causing pain and you are healthy enough for the procedure.

Hamburg

Hear when a new Type B Aortic Dissection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.